Benazepril: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) New page: <applet load="" size="480" color="" frame="true" spin="on" Scene ="Enalapril/Enal/1" align="right" caption="Enalaprilat, the metabolite of Enalapril, also known as Vasotec"/> ===Better ... |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<applet load="" size="480" color="" frame="true" spin="on" Scene ="Enalapril/Enal/1" align="right" caption="Enalaprilat, the metabolite of Enalapril, also known as Vasotec"/> | <applet load="" size="480" color="" frame="true" spin="on" Scene ="Enalapril/Enal/1" align="right" caption="Enalaprilat, the metabolite of Enalapril, also known as Vasotec"/> | ||
===Better Known as: | ===Better Known as: Lotensin=== | ||
* Marketed By: | * Marketed By: Novartis International AG<br /> | ||
* Major Indication: Hypertension & Congestive Heart Failure<br /> | * Major Indication: Hypertension & Congestive Heart Failure<br /> | ||
* Drug Class: [[ACE]] Inhibitor | * Drug Class: [[ACE]] Inhibitor | ||
* Date of FDA Approval (Patent Expiration): | * Date of FDA Approval (Patent Expiration): 1991 (2003)<br /> | ||
* | * 2002 Sales: $300 Million | ||
* Why You Should Care: One of the best selling [[Angiotensin-Converting Enzyme]] Inhibitors of all time | * Why You Should Care: One of the earliest and best selling [[Angiotensin-Converting Enzyme]] Inhibitors of all time. | ||
* The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | * The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | ||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
